KR850007561A - 제산제 함유거품 제조방법 - Google Patents

제산제 함유거품 제조방법 Download PDF

Info

Publication number
KR850007561A
KR850007561A KR1019850002662A KR850002662A KR850007561A KR 850007561 A KR850007561 A KR 850007561A KR 1019850002662 A KR1019850002662 A KR 1019850002662A KR 850002662 A KR850002662 A KR 850002662A KR 850007561 A KR850007561 A KR 850007561A
Authority
KR
South Korea
Prior art keywords
acid
medium
aqueous
containing foam
antacid
Prior art date
Application number
KR1019850002662A
Other languages
English (en)
Inventor
데이비드 부흘러 죤 (외 2)
Original Assignee
하버트 제이. 시나이더
로러 인터내셔널(오버시즈) 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하버트 제이. 시나이더, 로러 인터내셔널(오버시즈) 인코포레이티드 filed Critical 하버트 제이. 시나이더
Publication of KR850007561A publication Critical patent/KR850007561A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

내용 없음

Description

제산제 함유거품 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 수성 산매체와 접촉될때 비독성가스를 생성할수 있는 물질과, 탄산 마그네슘 과 알긴산을 수성매체에 혼합한후 그 혼합물의 pH를 약 7.5로 조절하여 제조된 알긴산 마그네슘으로 구성되고, 알긴산의 중합체사슬이 만누론산대 굴루론산의 비를 약 0.4대 2로 하여 만누론산과 글루론산 세그번트를 포함하는 재산제 조성물의 수성 현탁액과 산성매체를 접촉시킴으로써 산성수용액 매체의 표면위에 재산제-함유거품을 형성하는 방법.
  2. 제1항에 있어서, 상기 물질이 중탄산칼륨인 것을 특징으로 하는 방법.
  3. 제2항에 있어서, 상기 현탄액이 칼슘사카린 및 탄산 칼슘으로 부터 선택된 안정제를 포함하는 것을 특징으로 하는 방법.
  4. 제3항에 있어서, 현탁액이 구연산을 포함하는 것을 특징으로 하는 방법.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019850002662A 1984-04-19 1985-04-18 제산제 함유거품 제조방법 KR850007561A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60179684A 1984-04-19 1984-04-19
US601796 1984-04-19

Publications (1)

Publication Number Publication Date
KR850007561A true KR850007561A (ko) 1985-12-07

Family

ID=24408805

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850002662A KR850007561A (ko) 1984-04-19 1985-04-18 제산제 함유거품 제조방법

Country Status (11)

Country Link
EP (1) EP0179858B1 (ko)
JP (1) JPH0764737B2 (ko)
KR (1) KR850007561A (ko)
CN (1) CN85104754A (ko)
AT (1) ATE77750T1 (ko)
AU (1) AU578690B2 (ko)
CA (1) CA1259916A (ko)
DE (1) DE3586281T2 (ko)
ES (1) ES8706029A1 (ko)
FR (1) FR2563108B1 (ko)
WO (1) WO1985004806A1 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
DE3612086A1 (de) * 1986-04-10 1987-10-15 Bayer Ag Konservierte antacida-zubereitungen
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
AU728423B2 (en) * 1996-10-04 2001-01-11 Mcneil-Ppc, Inc. Methods and compositions for preventing and treating heartburn
KR20010020438A (ko) * 1997-04-30 2001-03-15 데일 마틴 주입가능한 알기네이트 조성물
WO2003043641A1 (en) * 2001-11-19 2003-05-30 Nobel Ilaç Sanayii Ve Ticaret A.S. New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
IT1406155B1 (it) * 2011-02-22 2014-02-14 Rossi Composizioni di alginato di magnesio e derivati come adiuvanti nel trattamento del reflusso gastrico
EA025430B1 (ru) 2012-01-27 2016-12-30 Государственное Научное Учреждение "Институт Биоорганической Химии Национальной Академии Наук Беларуси" Фармацевтическая композиция в качестве субстанции антирефлюксного антацидного препарата
CN104688765A (zh) * 2013-12-04 2015-06-10 博晖(大连)实业有限公司 一种由海藻酸盐组合的组方胃药
IT202100000059A1 (it) * 2021-01-04 2022-07-04 Nyuma Pharma Srl Nuove composizioni di sucralfato in alginato e loro utilizzo in terapia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1363399A (en) * 1972-04-13 1974-08-14 Rotta Research Lab Method of preparing an antacid pharmaceutical product
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
GB1598375A (en) * 1978-02-17 1981-09-16 Anphar Sa Aluminium magnesium carbonate

Also Published As

Publication number Publication date
EP0179858B1 (en) 1992-07-01
WO1985004806A1 (en) 1985-11-07
JPS61501916A (ja) 1986-09-04
EP0179858A1 (en) 1986-05-07
FR2563108B1 (fr) 1987-09-04
DE3586281D1 (de) 1992-08-06
AU578690B2 (en) 1988-11-03
EP0179858A4 (en) 1986-09-15
CN85104754A (zh) 1986-12-10
CA1259916A (en) 1989-09-26
ES542430A0 (es) 1987-06-01
DE3586281T2 (de) 1992-12-10
ES8706029A1 (es) 1987-06-01
JPH0764737B2 (ja) 1995-07-12
ATE77750T1 (de) 1992-07-15
FR2563108A1 (fr) 1985-10-25
AU4233685A (en) 1985-11-15

Similar Documents

Publication Publication Date Title
KR850007561A (ko) 제산제 함유거품 제조방법
ATE264267T1 (de) Verfahren zur herstellung von künstlichem zeolith
KR900700021A (ko) 냉동 분쇄 어육 첨가용 품질 개량제 및 이것을 사용한 냉동 분쇄어육의 제조방법
KR860003249A (ko) 피록시캄 1수화물의 제조 방법
KR870700354A (ko) 기포성 아세틸살리실산 정제의 개선
BR8207500A (pt) Composicao concentrada de espuma contra incendio com base aquosa, composicao aquosa, processo para a extincao de incendio
KR910004177A (ko) 발포성 제제 조성물
JPS5698482A (en) Corrosion inhibitor
KR840006126A (ko) 약학 조성물의 안정화 방법
KR840000234A (ko) (n-아세틸-파라-아미노페놀)-제산제 조성물
KR870000065A (ko) 약산성 목욕탕수 형성제
BR9804866A (pt) M-todo para a fabrica-Æo de um granulado para hemodi lise
NO20005725D0 (no) Biologisk aktiv sammensetning
KR890002301A (ko) 고압축 강도를 가진 밀폐된 셀형 포옴의 제조방법
ES448571A1 (es) Procedimiento para la estabilizacion de factor de aglutina- cion ligado a microorganismos.
KR850005383A (ko) 마사토를 이용한 벽돌 제조방법
KR910004498A (ko) 점토질 토양의 세멘트병용 경화제 조성물
KR920006585A (ko) 토질개량공법
KR880006995A (ko) 밤가루를 이용한 면류의 제조방법
KR870003721A (ko) 저나트륨 식염의 제조방법
KR850001133A (ko) 불소성 내화벽돌 제조방법
KR870000398A (ko) 세멘트 접착제의 제조방법
KR850006448A (ko) 폐기물(회분)을 이용한 연탄의 제조방법
KR850005775A (ko) 발포성 욕용제
KR880012265A (ko) 공기정화용 탈취제

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid